Measuring Fluid Buildup in Cancer Patients
Monitoring of Oedema in Cancer Patients - A Pilot Study
Jens Rikardt Andersen
46 participants
Feb 1, 2026
OBSERVATIONAL
Conditions
Summary
The goal of this study is to improve the monitoring of fluid retention in cancer patients. The main question it aims to answer is: Can segmental bioelectrical impedance analysis be used to monitor local fluid retention (edema) in cancer patients? We will include: * Breast cancer patients with fluid and or lymph retention in one or both arms after radiotherapy (outpatients) * Cancer patients with fluid retention in one or both legs after chemotherapy (hospitalized) Participants will: * Have measurements taken using bioelectrical impedance * Provide blood samples and 24-hour urine collection * Weight monitorering * Complete diet and fluid registration (inclusive enteral and parenteral) * Have clinical palpatory and measurement assessment of oedema.
Eligibility
Inclusion Criteria13
- Habile
- Must be able to speak and read Danish
- Has received/is receiving radiotherapy due to breast cancer within the last 6 months
- Is being followed in the Oncology Outpatient Clinic at Aalborg University Hospital
- Age ≥ 18 years
- Visible lymphoedema in at least one upper extremity
- Habile
- Must be able to speak and read Danish
- Has received/is receiving chemotherapy due to cancer within the last 2 months
- Hospitalised in the Oncology Ward at Aalborg University Hospital
- Estimated length of hospital stay of at least 6 days
- Age ≥ 18 years
- Visible peripheral oedema in at least one lower extremity
Exclusion Criteria9
- Pregnant or breastfeeding women
- Amputated limb(s)
- Pacemaker or implanted cardioverter-defibrillator due to risk of interference from the electrical signal
- Metallic prostheses due to risk of interference with the device signal
- Inability to lie still for the duration of the measurement interval (minimum 2 minutes at a time)
- Inability to stand on a scale, i.e. permanently bedridden.
- Inability to cooperate with urine collection
- Receiving dialysis
- Terminal illness
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07443618